Skip to main content

Table 3 Antimicrobials received in the ICU within the seven days prior to VAP onset

From: Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa

Antimicrobials

PSPA-VAP

(n= 153)

PRPA-VAP

(n= 70)

P-value

Penicillin

63 (41)

21 (30)

0.27

Cephalosporins 1, 2 or 3

46 (30)

22 (31)

0.99

Ceftazidime

7 (5)

3 (4)

0.99

Cephalosporins 4 (cefepim, cefpirome)

4 (3)

5 (7)

0.19

Piperacillin-Tazobactam

14 (9)

13 (19)

0.01

Ureidopenicillin - carboxypenicillin

20 (13)

22 (31)

0.0004

Tazobactam, sulbactam or Clavulanic acid

56 (37)

26 (37.1)

0.41

Penems

11 (7)

6 (8.6)

0.92

Fluoroquinolones

20 (13)

17 (24.3)

0.058

Aminoglycosides

38 (25)

21 (30)

0.24

Azoles

16 (10)

13 (19)

0.14

Glycopeptides

24 (16)

14 (20)

0.42

Other

14 (9)

8 (11)

0.99

At least one antimicrobial

101 (66)

44 (63)

0.60

  1. Data are the numbers (%).